BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 27913603)

  • 1. The tumor suppressor FLCN mediates an alternate mTOR pathway to regulate browning of adipose tissue.
    Wada S; Neinast M; Jang C; Ibrahim YH; Lee G; Babu A; Li J; Hoshino A; Rowe GC; Rhee J; Martina JA; Puertollano R; Blenis J; Morley M; Baur JA; Seale P; Arany Z
    Genes Dev; 2016 Nov; 30(22):2551-2564. PubMed ID: 27913603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myeloid Folliculin balances mTOR activation to maintain innate immunity homeostasis.
    Li J; Wada S; Weaver LK; Biswas C; Behrens EM; Arany Z
    JCI Insight; 2019 Mar; 5(6):. PubMed ID: 30843872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose tissue browning: mTOR branches out.
    Wada S; Arany Z
    Cell Cycle; 2017 Mar; 16(6):493-494. PubMed ID: 28135904
    [No Abstract]   [Full Text] [Related]  

  • 4. FLCN alteration drives metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland.
    Isono Y; Furuya M; Kuwahara T; Sano D; Suzuki K; Jikuya R; Mitome T; Otake S; Kawahara T; Ito Y; Muraoka K; Nakaigawa N; Kimura Y; Baba M; Nagahama K; Takahata H; Saito I; Schmidt LS; Linehan WM; Kodama T; Yao M; Oridate N; Hasumi H
    Biochem Biophys Res Commun; 2020 Feb; 522(4):931-938. PubMed ID: 31806376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment of folliculin to lysosomes supports the amino acid-dependent activation of Rag GTPases.
    Petit CS; Roczniak-Ferguson A; Ferguson SM
    J Cell Biol; 2013 Sep; 202(7):1107-22. PubMed ID: 24081491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of FLCN inhibits canonical WNT signaling via TFE3.
    Kennedy JC; Khabibullin D; Hougard T; Nijmeh J; Shi W; Henske EP
    Hum Mol Genet; 2019 Oct; 28(19):3270-3281. PubMed ID: 31272105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Birt-Hogg-Dubé syndrome: Clinical and molecular aspects of recently identified kidney cancer syndrome.
    Hasumi H; Baba M; Hasumi Y; Furuya M; Yao M
    Int J Urol; 2016 Mar; 23(3):204-10. PubMed ID: 26608100
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inactivation of the FLCN tumor suppressor gene induces TFE3 transcriptional activity by increasing its nuclear localization.
    Hong SB; Oh H; Valera VA; Baba M; Schmidt LS; Linehan WM
    PLoS One; 2010 Dec; 5(12):e15793. PubMed ID: 21209915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.
    Baba M; Hong SB; Sharma N; Warren MB; Nickerson ML; Iwamatsu A; Esposito D; Gillette WK; Hopkins RF; Hartley JL; Furihata M; Oishi S; Zhen W; Burke TR; Linehan WM; Schmidt LS; Zbar B
    Proc Natl Acad Sci U S A; 2006 Oct; 103(42):15552-7. PubMed ID: 17028174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folliculin impairs breast tumor growth by repressing TFE3-dependent induction of the Warburg effect and angiogenesis.
    El-Houjeiri L; Biondini M; Paquette M; Kuasne H; Pacis A; Park M; Siegel PM; Pause A
    J Clin Invest; 2021 Nov; 131(22):. PubMed ID: 34779410
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic AMPK activation via loss of FLCN induces functional beige adipose tissue through PGC-1α/ERRα.
    Yan M; Audet-Walsh É; Manteghi S; Dufour CR; Walker B; Baba M; St-Pierre J; Giguère V; Pause A
    Genes Dev; 2016 May; 30(9):1034-46. PubMed ID: 27151976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. AMPK promotes induction of the tumor suppressor FLCN through activation of TFEB independently of mTOR.
    Collodet C; Foretz M; Deak M; Bultot L; Metairon S; Viollet B; Lefebvre G; Raymond F; Parisi A; Civiletto G; Gut P; Descombes P; Sakamoto K
    FASEB J; 2019 Nov; 33(11):12374-12391. PubMed ID: 31404503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folliculin promotes substrate-selective mTORC1 activity by activating RagC to recruit TFE3.
    Li K; Wada S; Gosis BS; Thorsheim C; Loose P; Arany Z
    PLoS Biol; 2022 Mar; 20(3):e3001594. PubMed ID: 35358174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of folliculin (the BHD gene product) phosphorylation by Tsc2-mTOR pathway.
    Piao X; Kobayashi T; Wang L; Shiono M; Takagi Y; Sun G; Abe M; Hagiwara Y; Zhang D; Okimoto K; Kouchi M; Matsumoto I; Hino O
    Biochem Biophys Res Commun; 2009 Nov; 389(1):16-21. PubMed ID: 19695222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unique mutation, accelerated mTOR signaling and angiogenesis in the pulmonary cysts of Birt-Hogg-Dubé syndrome.
    Nishii T; Tanabe M; Tanaka R; Matsuzawa T; Okudela K; Nozawa A; Nakatani Y; Furuya M
    Pathol Int; 2013 Jan; 63(1):45-55. PubMed ID: 23356225
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of mTORC1 is essential for β-adrenergic stimulation of adipose browning.
    Liu D; Bordicchia M; Zhang C; Fang H; Wei W; Li JL; Guilherme A; Guntur K; Czech MP; Collins S
    J Clin Invest; 2016 May; 126(5):1704-16. PubMed ID: 27018708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrient-induced FNIP degradation by SCFβ-TRCP regulates FLCN complex localization and promotes renal cancer progression.
    Nagashima K; Fukushima H; Shimizu K; Yamada A; Hidaka M; Hasumi H; Ikebe T; Fukumoto S; Okabe K; Inuzuka H
    Oncotarget; 2017 Feb; 8(6):9947-9960. PubMed ID: 28039480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A FLCN-TFE3 Feedback Loop Prevents Excessive Glycogenesis and Phagocyte Activation by Regulating Lysosome Activity.
    Endoh M; Baba M; Endoh T; Hirayama A; Nakamura-Ishizu A; Umemoto T; Hashimoto M; Nagashima K; Soga T; Lang M; Schmidt LS; Linehan WM; Suda T
    Cell Rep; 2020 Feb; 30(6):1823-1834.e5. PubMed ID: 32049013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor Suppressor Folliculin Regulates mTORC1 through Primary Cilia.
    Zhong M; Zhao X; Li J; Yuan W; Yan G; Tong M; Guo S; Zhu Y; Jiang Y; Liu Y; Jiang Y
    J Biol Chem; 2016 May; 291(22):11689-97. PubMed ID: 27072130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constitutive adipocyte mTORC1 activation enhances mitochondrial activity and reduces visceral adiposity in mice.
    Magdalon J; Chimin P; Belchior T; Neves RX; Vieira-Lara MA; Andrade ML; Farias TS; Bolsoni-Lopes A; Paschoal VA; Yamashita AS; Kowaltowski AJ; Festuccia WT
    Biochim Biophys Acta; 2016 May; 1861(5):430-8. PubMed ID: 26923434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.